Skip to main navigation

Skip to Content

Regeneron.com Contact Us

News Events &
Presentations Stock
Information Financials Governance Resources

News Events & Presentations Stock Information Financials Governance Resources

Press Releases Media Statements

Upcoming & Recent Archive

Stock Information Historic Price Lookup Investment Calculator Ownership Profile

Financial Information SEC Filings Annual Reports & Proxy Statements Quarterly Results

Governance Documents Corporate Responsibility Committee Composition Contact the Board Insider Transactions

FAQs Pipeline Our Medicines

Regeneron.com Contact Us

news / Media Statements

Media Statements

View press releases

Year

Apr 15, 2024

Statement on Department of Justice Filing Related to EYLEA® (aflibercept) Injection 2 mg

Read media statement

Clinical Trials

Accessibility Statement

Social Media Terms

Privacy Preference Center

Copyright © 2025 Regeneron Pharmaceuticals Inc.. All rights reserved. All trademarks mentioned are the property of their respective owners.

You are now leaving Investor.Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

You are now leaving Investor.Regeneron.com to visit another Regeneron website.

You are now leaving Investor.Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.

You are now leaving Investor.Regeneron.com to visit another Regeneron website.